Adaptive T cell responses induced by oncolytic Herpes Simplex Virus-granulocyte macrophage-colony-stimulating factor therapy expanded by dendritic cell and cytokine-induced killer cell adoptive therapy

Jun RenBeijing Key Lab for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China;Department of Surgery, Duke University Medical Center, Durham, NC, USA

William R. GwinDepartment of Surgery, Duke University Medical Center, Durham, NC, USA

Xinna ZhouBeijing Key Lab for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China

Xiaoli WangBeijing Key Lab for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China

Hongyan HuangBeijing Key Lab for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China

Ni JiangBeijing Key Lab for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China

Lei ZhouBeijing Key Lab for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China

Pankaj AgarwalDepartment of Surgery, Duke University Medical Center, Durham, NC, USA

Amy HobeikaDepartment of Surgery, Duke University Medical Center, Durham, NC, USA

Erika CrosbyDepartment of Surgery, Duke University Medical Center, Durham, NC, USA

Zachary C. HartmanDepartment of Surgery, Duke University Medical Center, Durham, NC, USA

Michael A. MorseDepartment of Medicine, Duke University Medical Center, Durham, NC, USA

Kevin H. EngDepartment of Biostatistics and Bioinformatics, Roswell Park Cancer Institute, Buffalo, NY, USA

H. Kim LyerlyDepartment of Surgery, Duke University Medical Center, Durham, NC, USACorrespondence[email protected]

show all

Adaptive T cell responses induced by oncolytic Herpes Simplex Virus-granulocyte macrophage-colony-stimulating factor therapy expanded by dendritic cell and cytokine-induced killer cell adoptive therapy

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Adaptive T cell responses induced by oncolytic Herpes Simplex Virus-granulocyte macrophage-colony-stimulating factor therapy expanded by dendritic cell and cytokine-induced killer cell adoptive therapy

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date